INTRODUCTION
Colorectal cancer has an incidence of approximately 150,000 per year in the United States and is the third leading cause of cancerrelated deaths in both men and women [1] . Although surgery, chemotherapy and radiotherapy [2] [3] [4] have been the mainstay of colorectal cancer treatment, traditional Chinese medicine (TCM) has the advantage of reducing cancer therapy-induced toxicity and is a popular form of complementary and alternative medicine (CAM) in China [5] . In recent years, with increased popularity with patients in China, the traditional Chinese medicine has been shown to further minimize the side effects of surgery, radiation and chemotherapy [6] , increase immune function [7] and improve survival [8] . Gamellia sinensis O.Ktze has been a widely used and well-documented medicinal plant for centuries [9, 10] . However, the anticancer properties of Gamellia sinensis O.Ktze have not been fully investigated and proven. In this study, we aim to explore the mechanism of GSOE in colorectal cancer suppression. 
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EXPERIMENTAL
Cell lines
Human colorectal cancer HCT-116 cells and Caco-2 cells were obtained from the cell bank of the Chinese Academy of Sciences (CAS) and maintained in RPMI 1640 medium supplemented with 10 % (v/v) heat-inactivated fetal calf serum, 2 mM glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin (Invitrogen, Carlsbad, CA) at 37 ℃ in a 5 % CO 2 humidified atmosphere. These two cell lines were used for testing the effects of GSOE on colorectal cancer.
MTT assays
To determine whether GSOE could suppress the growth of colorectal cancer cells, GSOE drug sensitivity in colorectal cancer cells was determined using the MTT assay. Briefly, cells were trypsinized and plated out into 96 well plates at a density of 3 × 10 3 cells per well. Cells were cultured overnight and re-fed with fresh medium containing various concentrations of GSOE (10, 50 or 100 mg/mL). The cell viability was examined at 0, 12, 24, 36 and 48 h after GSOE was added. Thereafter, 50 L 3-(4, 4-dimethylthiazol-2-yl)-2, 5-dipheny-ltetrazolium bromide (MTT) (Sigma-Aldrich, St. Louis, MO) in PBS was added to each well, incubated for 4 h at 37 o C and the formazan crystals that formed were dissolved in 150 L dimethyl sulfoxide. The optical density was recorded at 490 nm on a micro-plate reader (Bio-Rad, Hercules, CA).
Flow cytometry analysis
To determine apoptosis of colorectal cancer cells, HCT-116 and Caco-2 cells were seeded in 6-well plates (4 × 10 5 / well) and treated with 100 mg/ml GSOE for 24 h, every group had 3 replicates. The cells were subjected to flow cytometry analysis using annexin V apoptosis detection kit (Becton Dickinson, NJ, USA). The cells were stained with annexin V-fluorescein isothiocyanate (FITC), propidium iodide (PI) for 25 min, and then analyzed by flow cytometry (Thermo Fisher, USA). FACS data were analyzed using FlowJo software (Tree Star, Inc.). For cell cycle analysis, cells were fixed with 500 L of pre-cooling 70 % ethanol at 4 °C overnight. Then, 300 L of RnaseA-containing PI staining solution was added to incubate at room temperature for 30 min. After washing with PBS, the absorbance was measured with flow cytometry and the results were analyzed using ModiFit.
Tumor animal model
Six to eight-weeks-old BALB/c (nu/nu) mice were purchased from Shanghai SLAC Laboratory Animal Co. All mice were maintained in a barrier facility at the Animal Center of Zhejiang University. The animals had free access to food and water, and were allowed to acclimatize for at least one week before use. The rat experiment was approved by the Animal Care and Use Committee of Zhejiang University (approval ref no. 201250306) and was carried out in compliance with Directive 2010/63/EU on the handling of animals used for scientific purposes [11] .
HCT-116 or Caco-2 cells with the concentration of 1.0 × 10 6 were implanted subcutaneously (s.c.) into the right flank of the mice. All tumor-bearing mice were randomly divided into four groups with 5 mice per group. The mice received 200, 400 or 800 mg/mL of GSOE by gastric perfusion everyday post tumor cell inoculation. Untreated mice were considered as the control. Tumor volume was measured every two days. After the mice were sacrificed, the lungs were removed and immersed in cold PBS for 2 -3 h, the gray nodules on the surface of the lungs were counted.
Western blot analysis
HCT-116 and Caco-2 cells were treated with 10, 50 or 100 mg/mL GSOE for 24 h, untreated cells were considered as the group control. All cells were treated with RIPA lysis buffer (Beyotime, China) containing protease inhibitor cocktail (Roche, Mannheim, Germany). Protein were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane. After blocking with 5 % fat-free milk, the membrane was probed with primary anti-p-ERK (dilution 1 : 1000; Cell Signal Technology), anti-p-MEK (dilution 1 : 1000, Santa Cruz) and anti-Actin (dilution 1 : 2000; Santa Cruz) antibody. After washing, the membrane was incubated with horseradish peroxidase-conjugated (HRP) secondary antibody for 1 h. The signal was visualized using the ECL detection system (Thermo Fisher, USA) and quantified by densitometry using Quantity One software (BioRad, Hercules, CA, USA).
Invasive assay
Transwell chambers with Matrigel (BD Bioscience, USA) were used to evaluate the cell invasion. HCT116 or Caco-2 cells were incubated with or without 100 mg/ml GSOE in the upper chambers of a Transwell plate (Corning, USA) with serum-free medium. Lower chambers with polycarbonate membranes, received 10 % FBS-containing medium, served as the attractant. After 24 h, the cells in the upper chambers were removed; migrated cells on the lower side were observed after they were fixed with 4 % paraformaldehyde and stained with crystal violet under a microscope. Migrating cells in five fields on each chamber were counted to calculate the invasion of colorectal cancer cells.
Statistical analysis
Statistical analysis was performed for all the data using Student's t-test. All the results are presented as mean ± standard error of mean (SEM). P < 0.05 was considered as statistically significant. All the tests were carried out using Prism 6 software (Graphpad Prism 6).
RESULTS
GSOE suppresses the growth of colorectal cancer cells in vitro
We tested the effects of GSOE on the growth of HCT-116 human colorectal cancer cells in vitro. GSOE induced a concentration-dependent decrease in cell growth and cell viability in HCT-116 ( Figures 1A and 1B) and Caco-2 cells ( Figures 1C and 1D) , as analyzed by MTT assay. These data indicated that GSOE suppresses the growth of colon cancer cells. 
GSOE induces apoptosis and cell cycle arrest at G1 to S phase in colorectal cancer cells
Flow cytometry analysis showed a significant increase in the number of cells in the proliferative G1-phase and a significant decrease in the number of cells in the G2-phase after 48 h of treatment with GSOE ( Figure 2A) . These results indicate cell cycle arrest at the S-phase after treatment of HCT-116 cells with GSOE. We evaluated the effects of GSOE on apoptosis in colorectal cancer cells by using Annexin V-FITC and PI staining. We observed a remarked increase in late apoptotic rate in both HCT-116 and Caco-2 cells, as assessed by flow cytometry, after GSOE treatment compared with untreated cells ( Figure 2B ). These data indicated that GSOE induced colorectal cancer cell death by promoting apoptosis promotion and cell cycle arrest.
The invasion of colorectal cancer cell is reduced by GSOE treatment
We examined whether GSOE attenuated the motility of colorectal cancer cells using transwell assay. Cell invasion increased after 24 h for the untreated group, but was substantially reduced when GSOE was present (Figure 3) . These results suggest that GSOE inhibited invasion of colorectal cancer cells.
GSOE suppresses growth and lung metastasis of colorectal cancer in vivo
To extensively confirm our findings in vivo, we generated a xenograft mouse model inoculated with HCT-116 or Caco-2 cells. The growth of these two tumors was suppressed by GSOE (gastric perfusion) in a concentration-dependent manner ( Figure 4A and 4B) . Moreover, the metastasis in the lung was also remarkably reduced with GSOE treatment (Figure 4 C and  D) . Taken together, we conclude that GSOE suppresses growth and lung metastasis of colorectal cancer. 
Effect of GSOE on ERK/MAPK signaling pathway in colorectal cancer cells
In order to investigate the mechanism of inhibition of GSOE on colorectal cancer cells, we evaluated the effects of GSOE on ERK/MAPK signaling pathway in HCT-116 cells and Caco-2 cells. We determined the level of phosphorylation of ERK and MAPK which were treated with different concentration of GSOE for 24 h. Western blot indicated that GSOE suppressed the phosphorylation of both ERK and MEK in HCT-116 cells or Caco-2 cells ( Figure 5 ). All in all, we conclude that GSOE impairs ERK/MAPK signaling pathway to suppress the growth and invasion of colorectal cancer. 
DISCUSSION
Thea viridis (Camellia sinensis) is a species of plant whose leaves are used to produce Chinese and Indian teas. The leaves have been used in traditional Chinese medicine and other medical systems to treat asthma [12] , peripheral vascular disease [13] and coronary artery disease [14, 15] . The results of the present study show that GSOE acts as a tumor suppressor in colorectal cancers via apoptosis by ERK/MAPK signaling pathway inhibition.
Firstly, we used three concentration of GSOE to treated HCT-116 and Caco-2 cells which were both colorectal cancer cells. Using MTT assay, we confirmed that GSOE inhibited the growth of these two cells at different concentration of GSOE. In order to test how GSOE suppressed the growth of colorectal cancer cells, we explored the apoptotic rate of HCT-116 and Caco-2 cells with GSOE treatment for about 24 h. Flow cytometry analysis suggested that GSOE increased the apoptotic rate of the colorectal cancer cells. Moreover, we also showed that GSOE induced cell cycle arrest at G1 to S phase in colorectal cancer cells. These results indicated that the inhibitory role of GSOE in colorectal cancer cells was attributable to cell cycle arrest and induction of apoptosis.
Notably, approximately half of colorectal cancer patients develop distant metastases, especially lung metastases, which are the main cause of death in patients [16, 17] . Tumor metastasis is a complex process that consists of multiple sequential steps, including the invasion of cancer cells into surrounding tissues, intravasation, extravasation, and growth in distant organs [18] . However, whether GSOE affected the metastasis of colorectal cancer was not clear. To address this question, we determined the invasion of HCT-116 and Caco-2 cells. To count the cells in lower chambers, we demonstrated that GSOE significantly inhibited the invasion of colorectal cancer cells in vitro. Furthermore, we also used xenograft tumor model to confirm the above results. As we expected, the HCT-116 and Caco-2 tumor growth were suppressed with three different concentration of GSOE treatment and the lung metastase were decreased.
Mitogen-activated protein kinase (MAPK) pathways link extracellular signals to their intracellular targets and control fundamental cellular processes such as cell proliferation, cell growth, cell migration, cell differentiation and cell death [19] . GSOE treatment increases ROS generation through the action on calmodulindependent protein kinase kinase [20] . However, ROS can activate 5'-AMP-activated protein kinase (AMPK). Hwang et al. demonstrated that GSOE treatment of colon cancer cells resulted in a strong activation of AMPK in association with an inhibition of COX-2 expression [21] . The decreased COX-2 expression as well as prostaglandin E2 secretion was abolished by an AMPK inhibitor, Compound C, suggesting that AMPK can be a target for an anti-cancer strategy. There are many molecules in MAPK signaling pathways such as ERK1/2, p38, MEK and JNK [22] . GSOE-derived-epigallocatechin gallate inhibits the growth of human villous trophoblasts via the ERK, p38, AMP-activated protein kinase, and AKT pathways. GSOE derived apigenin is also an invaluable chemopreventive agent that inhibits progression and metastasis of choriocarcinoma cells through regulation of PI3K/AKT and ERK1/2 MAPK signal transduction mechanism [23] . To investigate the mechanism of GSOE inhibition of colorectal cancer, we determined level of ERK signaling pathways including ERK1/2 and MEK. The result from western blot analysis indicated that the phosphorylation of ERK1/2 and MEK2 were remarkably decreased with PVE treatment of HCT-116 and Caco-2 cells.
CONCLUSION
The findings of this study show that GSOE suppresses colorectal cancer cell growth and metastasis which is attributable to the increased apoptotic rate and cell cycle arrest by ERK/MAPK signaling pathway inhibition. Thus, this agent has potentials to be developed for the management of colorectal cancer.
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